Literature DB >> 27755127

Mechanism of granuloma formation in sarcoidosis.

Priya Sakthivel1, Dunja Bruder.   

Abstract

PURPOSE OF REVIEW: The formation of noncaseating granuloma is a hallmark of pulmonary sarcoidosis. This review summarizes recent progress made to explain the cellular dynamics within the granuloma structure that may considerably differ between the two clinically distinct variants, that is, acute and chronic sarcoidosis. RECENT
FINDINGS: Compelling evidence exists that in acute but not chronic sarcoidosis CD4 T lymphocytes specifically recognizing the auto-antigen vimentin on human leukocyte antigen-DR3 molecules accumulate in sarcoid granuloma. These so-called TH17.1 cells produce high amounts of the TH17-related cytokines interleukin-17 (IL-17) and IL-22 in addition to interferon-γ. Moreover, regulatory T cells from patients with acute sarcoidosis are ICOS, providing a mechanistic link to the comparably high concentration of IL-10 exclusively found in the airways of these patients. Next to obvious differences in T effector cell and Treg subsets, alveolar macrophages harbor a functional mitochondrial system in acute sarcoidosis patients, while this system is impaired in patients with chronic disease.
SUMMARY: We provide a comprehensive update on the cellular components and their functional implications in sarcoid granuloma formation, with special emphasis on the specific characteristics of granuloma in acute versus chronic sarcoidosis. Moreover, the specific antigens thought to be involved in both forms of the disease are discussed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27755127     DOI: 10.1097/MOH.0000000000000301

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  29 in total

Review 1.  [Sarcoidosis : Dermatological view of a rare multisystem disease].

Authors:  T Giner; S Benoit; H Kneitz; M Goebeler
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

Review 2.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

Review 3.  [What is a granuloma?]

Authors:  E von Stebut
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

4.  Inflammatory Pathways in Sarcoidosis.

Authors:  Barbara P Barna; Marc A Judson; Mary Jane Thomassen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 5.  Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic.

Authors:  Bogna Grygiel-Górniak
Journal:  Clin Rheumatol       Date:  2021-07-03       Impact factor: 3.650

6.  G908R NOD2 variant in a family with sarcoidosis.

Authors:  Valérie Besnard; Alain Calender; Diane Bouvry; Yves Pacheco; Catherine Chapelon-Abric; Florence Jeny; Hilario Nunes; Carole Planès; Dominique Valeyre
Journal:  Respir Res       Date:  2018-03-20

7.  T-bet Expression in Peripheral Th17.0 Cells Is Associated With Pulmonary Function Changes in Sarcoidosis.

Authors:  Nicholas K Arger; Siddharth Machiraju; Isabel E Allen; Prescott G Woodruff; Laura L Koth
Journal:  Front Immunol       Date:  2020-07-22       Impact factor: 7.561

Review 8.  Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.

Authors:  Raisa Kraaijvanger; Montse Janssen Bonás; Adriane D M Vorselaars; Marcel Veltkamp
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

9.  Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment.

Authors:  Léa Paolini; Caroline Poli; Simon Blanchard; Thierry Urban; Anne Croué; Marie-Christine Rousselet; Sarah Le Roux; Nathalie Labarrière; Pascale Jeannin; José Hureaux
Journal:  J Immunother Cancer       Date:  2018-06-13       Impact factor: 13.751

10.  Successful therapy with rituximab in three patients with probable neurosarcoidosis.

Authors:  Samis Zella; Janina Kneiphof; Aiden Haghikia; Ralf Gold; Dirk Woitalla; Jan Thöne
Journal:  Ther Adv Neurol Disord       Date:  2018-10-26       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.